NRC Health Announces Q1 Results and Share Repurchase

National Research ( (NRC) ) just unveiled an announcement.

On April 28, 2025, NRC Health announced its first quarter results, highlighting a sequential increase in total recurring contract value, expansion of its sales force, and a new share repurchase program. The company also declared a quarterly cash dividend and completed a prior share repurchase program. These developments reflect NRC Health’s strategic focus on revenue growth and shareholder returns, with significant contributions from its leadership team.

Spark’s Take on NRC Stock

According to Spark, TipRanks’ AI Analyst, NRC is a Neutral.

National Research Corporation’s stock score reflects significant financial challenges, particularly in profitability and balance sheet transparency. However, strong cash flows and a low valuation indicate some resilience. Recent leadership changes offer potential for future improvement, but technical analysis currently shows a bearish trend, highlighting short-term risks. The valuation remains attractive, providing a buffer against these challenges.

To see Spark’s full report on NRC stock, click here.

More about National Research

National Research Corporation, operating as NRC Health, is a company focused on providing healthcare systems with insights to personalize patient, caregiver, and community relationships. For over 40 years, NRC Health has been committed to enhancing Human Understanding® in the healthcare industry.

YTD Price Performance: -38.70%

Average Trading Volume: 90,988

Technical Sentiment Signal: Buy

Current Market Cap: $244.3M

Find detailed analytics on NRC stock on TipRanks’ Stock Analysis page.